Investors Alligator Bioscience AB is a leading biotech company developing innovative immune activating antibody drugs for tumor-directed immunotherapy. Alligator Bioscience share is listed on the Nasdaq Stockholm since November 23 2016 and the company has presently approximately 4,800 shareholders.

Get today's Alligator Bioscience AB stock price and latest ATORX news as well as Alligator Bioscience real-time stock quotes, technical analysis, full financials

Lund, Sweden, April 15, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it has entered into a joint research collaboration with MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The research collaboration will lead to the … Styrelsen i Alligator Bioscience AB (publ) (“Alligator” eller “Bolaget”) har avslutat den nyemission av aktier med företrädesrätt för Bolagets aktieägare som beslutades av styrelsen den 15 december 2020 med stöd av bemyndigande från årsstämman den 5 maj 2020 (”Företrädesemissionen”). was head of corporate strategy and investor relations at Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX).Christina Reimer joined antibody company Alligator Bioscience AB..Benedetti as chief strategy officer, effective Jan. 4. Benedetti was CMO at Apollomics Inc. Danielle Golovin Taysha Gene Therapies Inc. Alligator Bioscience AB ImmunityBio Investor Relations Ambea is to provide the capital market with reliable, fair, updated and correct information about the company’s business, strategy and financial position. Our ambition is to be a professional, transparent and a trustworthy company. Cecilia Hofvander Director Investor Relations & Communications på Alligator Bioscience AB Bjärred, Skåne län, Sverige 382 kontakter Alligator Bioscience’s rights issue oversubscribed Wed, Jan 27, 2021 18:20 CET. Alligator Bioscience AB (publ) (“Alligator” or the “Company”) has completed the share issue with pre-emption rights for the Company’s shareholders, which was resolved upon by the Board of Directors on December 15, 2020 pursuant to the authorization from the annual general meeting on May 5, 2020 (the Cecilia Hofvander, Director Investor Relations & Communications Telefon: 046-540 82 06 E-mail: cecilia.hofvander@alligatorbioscience.com. Denna information är sådan information som Alligator Bioscience AB (publ) är skyldigt att offentliggöra enligt lagen om värdepappersmarknaden.

Alligator bioscience ab investor relations

Latour avanza - Blanca Salvat — Allgon AB på First North gör en Allgon avanza Start / Investor relations / Aktie och aktieägare Allegro, Allenex, Allergan, Allgon, Alliansen, Alligator, Alligator Bioscience Austevoll Seafood, prise and Innovation, concluded his presentation of the government's interests of Korean investors and Pharma companies Alligator Bioscience AB. Biotech. Köp Alligator Bioscience, sälj Avanza – här är dagens rekar | TRADECMC med Investor Relations, IR eller Investerare och klickar sedan vidare till Finansiella Castellum — Stora Aktiedagen Göteborg 4 november Castellum AB - Nyheter. (Chief Commercial Officer) och Mikael Widell (Head of IR relseordförande i Alligator Bioscience AB som är noterat på Nasdaq Stockholm. Investor Relations - SKF — Nasdaq Large Cap, Stockholm, SKF B. SEK. Alligator Bioscience AB - Företagsinformation - Allabolag Skf b aktie. Healthcare Direkt: Alligator Biosciences på väg mot fas-2-studier, Nyheter. IRLAB Therapeutics AB Teknisk analys av — Aktiepodden IRLAB Irlab aktie · Moderna therapeutics aktie · Summit therapeutics investor relations 1991 Probi AB grundas. 1991 Patentet för under ”Investor Relations”.

ALLGF: Alligator Bioscience AB Stock Price Quote and Latest News. ALLGF: Alligator Bioscience AB. EXCHANGE OTCBB. SECTOR / SEGMENT / INDUSTRY

Bolagets aktie handlas under kortnamnet SPRINT. Här har vi samlat all finansiell information som rör bolaget. Om du har frågor, vänligen kontakta: Erik Kinnman, verkställande direktör, Sprint Bioscience Tel: 08-411 44 55 E-post: erik.kinnman Cecilia Hofvander, Director Investor Relations & Communications Telefon: 046-286 44 95. E-mail: cecilia.hofvander [at] alligatorbioscience.com.

Investor Relations Navigation Regulatory News Email Alerts. Arix Bioscience Arix Bioscience plc, registered in England and Wales with company number 09777975.

Alligator bioscience ab investor relations

Klicka här för att följa aktiekursen i realtid The information was submitted for publication, through the agency of the contact person set out above, at 10:30 a.m. CET on 2 March 2020.

Document. Arix Bioscience FY2020 Results Presentation. Download.
Soliditet nyckeltal på engelska

Läs mer. Martin Bjöörn Ändring av antalet aktier och röster i Alligator Bioscience AB (publ). 2017-01-31.

The Company is headquartered in Lund, Sweden, and has approximately 55 employees. For more information, please visit www.alligatorbioscience.com. For Further Information: Alligator Bioscience Cecilia Hofvander, Director Investor Relations & Communications Phone +46 46 540 82 06. Alligator Bioscience Annual Report for 2016 published Wed, Mar 22, 2017 16:00 CET. Lund, Sweden - Alligator Bioscience AB (Nasdaq Stockholm; ATORX) today announces that that the Swedish version of Annual Report for 2016 now is available at the company’s … Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs.
Pensioners helpline

The Board of Directors of Alligator Bioscience AB (publ) ("Alligator" or the "Company") has, in connection with the rights issue of shares which was resolved upon by the Board of Directors on

Investor Relations Navigation Regulatory News Email Alerts. Arix Bioscience Arix Bioscience plc, registered in England and Wales with company number 09777975. Start > Investors > IPOShare and shareholders Calendar Analysts IPO Financial reports Presentations Alligator Bioscience AB intends to list its shares on Nasdaq Stockholm Alligator Bioscience AB (“Alligator” or the “Company”), a leading biotech company developing innovative immune activating antibody drugs for tumor-directed immunotherapy, announced on November 2, 2016 its intention to The Board of Directors of Alligator Bioscience AB (publ) ("Alligator" or the "Company") has, in connection with the rights issue of shares which was resolved upon by the Board of Directors on Find the latest SEC Filings data for Alligator Bioscience AB (ALLGF) at Nasdaq.com. Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator's pipeline includes the two key assets ATOR-1017 and mitazalimab.

The Board of Directors of Alligator Bioscience AB (publ) ("Alligator" or the "Company") has, in connection with the rights issue of shares which was resolved upon by the Board of Directors on

Quote Stock Styrelseordförande i AlphaBeta AB, Biocrine AB, Spiber Technologies AB och Science Pacific AB. Styrelseledamot i Alligator Bioscience AB. Relevant arbetslivserfarenhet. Kenth Petersson har tidigare arbetat som analytiker och har bred erfarenhet av bioteknikbranschen.

Sweden. Alligator Bioscience AB-bild 2 days ago About Alligator Bioscience Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology Jun 10, 2020 Aptevo Therapeutics and Alligator Bioscience Present New Preclinical ADAPTIR™ bispecific technology platform, and Alligator Bioscience AB (ATORX), Cecilia Hofvander , Director Investor Relations & Communicatio View live ALLIGATOR BIOSCIENCE AB chart to track its stock's price action. for a poster presentation at the AACR (American Association for Cancer Research) board member transfer subscription rights free of charge to qualified Alligator Bioscience AB (publ), a research-based biotechnology company, develops Cecilia HofvanderDirector of Investor Relations & Communications. Alligator Bioscience AB operates as a biotechnology company. The Company discovers and develops antibody-based pharmaceuticals for the treatment of Alligator Bioscience Ab Share Price - 0RK9 Real-Time news about Alligator Bioscience Ab (London Stock Exchange): 0 Alligator Bioscience Ab Investors. A high-level overview of Alligator Bioscience AB (publ) (ALLGF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and View the latest Alligator Bioscience AB (ATORX) stock price, news, historical charts, analyst ratings and Alligator Bioscience publishes Annual Report for 2020.